Journal ArticleDOI
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
A. Michael Lincoff,John A. Bittl,Robert A. Harrington,Frederick Feit,Neal S. Kleiman,J. Daniel Jackman,Ian J. Sarembock,David J. Cohen,Douglas Spriggs,Ramin Ebrahimi,Gadi Keren,Jeffrey Carr,Eric A. Cohen,Amadeo Betriu,Walter Desmet,Dean J. Kereiakes,Wolfgang Rutsch,Robert G. Wilcox,Pim J. de Feyter,Alec Vahanian,Eric J. Topol +20 more
TLDR
The REPLACE-2 Investigators include Dr. Michael Lincoff, MD John A. Bittl, MD Robert A. Harrington, MD Frederick Feit, MD Neal S. Kleiman, MD J.A. Sarembock, MD David J. Cohen, MD Douglas Spriggs, MD Ramin Ebrahimi, MD Gadi Keren, MD Jeffrey Carr, MD Eric A. Topol, MD for the REPLace-2 investigators.Abstract:
A. Michael Lincoff, MD John A. Bittl, MD Robert A. Harrington, MD Frederick Feit, MD Neal S. Kleiman, MD J. Daniel Jackman, MD Ian J. Sarembock, MD David J. Cohen, MD Douglas Spriggs, MD Ramin Ebrahimi, MD Gadi Keren, MD Jeffrey Carr, MD Eric A. Cohen, MD Amadeo Betriu, MD Walter Desmet, MD Dean J. Kereiakes, MD Wolfgang Rutsch, MD Robert G. Wilcox, MD Pim J. de Feyter, MD Alec Vahanian, MD Eric J. Topol, MD for the REPLACE-2 Investigatorsread more
Citations
More filters
Journal ArticleDOI
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
Sidney C. Smith,Ted Feldman,John W. Hirshfeld,Alice K. Jacobs,Morton J. Kern,Spencer B. King,Douglass A. Morrison,William W. O'Neill,Hartzell V. Schaff,Patrick L. Whitlow,David O. Williams,Elliott M. Antman,Cynthia D. Adams,Jeffrey L. Anderson,David P. Faxon,Valentin Fuster,Jonathan L. Halperin,Loren F. Hiratzka,Sharon A. Hunt,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel +22 more
TL;DR: The American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions (ACC/AHA/SCAI) 2005 Guideline Update for Percutaneous Coronary Intervention (PCI) contains changes in the recommendations, along with supporting text.
Journal ArticleDOI
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial
Steven V. Manoukian,Frederick Feit,Roxana Mehran,Michele D. Voeltz,Ramin Ebrahimi,Martial Hamon,George Dangas,A. Michael Lincoff,Harvey D. White,Jeffrey W. Moses,Spencer B. King,E. Magnus Ohman,Gregg W. Stone +12 more
TL;DR: In this article, a logistic regression was used to determine predictors of 30-day major bleeding and mortality in patients with acute coronary syndromes (ACS) undergoing an early invasive strategy and showed that major bleeding rates in patients treated with heparin plus glycoprotein IIb/IIIa inhibition were higher versus bivalirudin monotherapy.
Journal ArticleDOI
Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement
Willibald Hochholzer,Dietmar Trenk,Hans-Peter Bestehorn,Benjamin Fischer,Christian M. Valina,Miroslaw Ferenc,Michael Gick,Angelika Caputo,Heinz Joachim Büttner,Franz-Josef Neumann +9 more
TL;DR: The level of platelet aggregation immediately before elective coronary stenting in patients pre-treated with a high loading dose of clopidogrel is correlated with early outcome after the procedure, and this is a significant independent predictor of 30-day MACE.
Journal ArticleDOI
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.
Gjin Ndrepepa,Peter B. Berger,Julinda Mehilli,Melchior Seyfarth,Franz-Josef Neumann,Albert Schömig,Adnan Kastrati +6 more
TL;DR: A strong relationship between the 30-day frequency of bleeding and 1-year mortality after PCI is demonstrated and supports the inclusion of periprocedural bleeding in a 30- day quadruple end point for the assessment of outcome after PCI.
Journal ArticleDOI
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
Sidney C. Smith,Ted Feldman,John W. Hirshfeld,Alice K. Jacobs,Morton J. Kern,Spencer B. King,Douglass A. Morrison,William W. O'Neill,Hartzell V. Schaff,Patrick L. Whitlow,David O. Williams,Elliott M. Antman,Cynthia D. Adams,Jeffrey L. Anderson,David P. Faxon,Valentin Fuster,Jonathan L. Halperin,Loren F. Hiratzka,Sharon A. Hunt,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel +22 more
References
More filters
Journal ArticleDOI
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.
Frederick Wolfe,Hugh A. Smythe,Muhammad B. Yunus,Robert M. Bennett,Claire Bombardier,Don L. Goldenberg,Peter Tugwell,Stephen M. Campbell,Micha Abeles,Patricia Clark,Adel G. Fam,Stephen J. Farber,Justus J. Fiechtner,C. Michael Franklin,Robert A. Gatter,Daniel Hamaty,James A. Lessard,Alan S. Lichtbroun,Alfonse T. Masi,Glenn A. McCain,W. John Reynolds,Thomas J. Romano,I. Jon Russell,Robert P. Sheon +23 more
TL;DR: Criteria for the classification of fibromyalgia are widespread pain in combination with 2) tenderness at 11 or more of the 18 specific tender point sites, and no exclusions are made for the presence of concomitant radiographic or laboratory abnormalities.
Journal ArticleDOI
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.
TL;DR: Ischemic complications of coronary angioplasty and atherectomy were reduced with a monoclonal antibody directed against the platelet IIb/IIIa glycoprotein receptor, although the risk of bleeding was increased.
Journal ArticleDOI
A national survey of stress reactions after the September 11, 2001, terrorist attacks.
Mark A. Schuster,Bradley D. Stein,Lisa H. Jaycox,Rebecca L. Collins,Grant N. Marshall,Marc N. Elliott,Annie Jie Zhou,David E. Kanouse,Janina L. Morrison,Sandra H. Berry +9 more
TL;DR: After the September 11 terrorist attacks, Americans across the country, including children, had substantial symptoms of stress, and clinicians who practice in regions that are far from the recent attacks should be prepared to assist people with trauma-related Symptoms of stress.
Journal ArticleDOI
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
TL;DR: Platelet glycoprotein-IIb/IIIa blockade with abciximab substantially improves the safety of coronary-stenting procedures and is safer than stenting without abcximab.
Journal ArticleDOI
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
TL;DR: Cl clot-bound thrombin is relatively protected from inhibition by heparin, and antithrombin III-independent inhibitors may be more effective than hepar in certain clinical settings.
Related Papers (5)
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial
A. Michael Lincoff,John A. Bittl,Robert A. Harrington,Frederick Feit,Neal S. Kleiman,J. Daniel Jackman,Ian J. Sarembock,David J. Cohen,Douglas Spriggs,Ramin Ebrahimi,Gadi Keren,Jeffrey Carr,Eric A. Cohen,Amadeo Betriu,Walter Desmet,Dean J. Kereiakes,Wolfgang Rutsch,Robert G. Wilcox,Pim J. de Feyter,Alec Vahanian,Eric J. Topol +20 more
Randomised placebo-controlled and balloon-angioplasty- controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
Bivalirudin for Patients with Acute Coronary Syndromes
Gregg W. Stone,Brent T. McLaurin,David A. Cox,Michel E. Bertrand,A. Michael Lincoff,Jeffrey W. Moses,Harvey D. White,Stuart J. Pocock,James H. Ware,Frederick Feit,Antonio Colombo,Philip E. Aylward,Angel Cequier,Harald Darius,Walter Desmet,Ramin Ebrahimi,Martial Hamon,Lars Hvilsted Rasmussen,Hans J. Rupprecht,James W. Hoekstra,Roxana Mehran,E. Magnus Ohman +21 more